
Memory-Restoring Brain-Implants Start Phase 3 Alzheimer’s Trials
VIDEO + ARTICLE: Scientists are applying an FDA-approved technique, Deep Brain Stimulation, to treat mild Alzheimer’s for 150 patients in Phase-3 clinical trials. Learn more.

VIDEO + ARTICLE: Scientists are applying an FDA-approved technique, Deep Brain Stimulation, to treat mild Alzheimer’s for 150 patients in Phase-3 clinical trials. Learn more.

In a first-of-its-kind study, FDA-Approved Dantrolene, a muscle relaxant, was delivered through the nose to Alzheimer’s lab animals. It eased their Alzheimer’s by providing therapeutic

VIDEO + ARTICLE: An experimental drug produced by Annovis has received its generic name following successful completion of its Phase II trials. Buntanetap is intended

MEDICATION: THE WORLD’S MOST POPULAR DEMENTIA-DRUG IS DONEPEZIL. Donepezil (Brand-name: Aricept®) boosts memory & thinking in Alzheimer’s. More donepezil means more boost – along with

PROGRESS IN THE NEWS – VIDEO & ARTICLE: In the lab, Alzheimer’s was delayed by FDA-approved “Dabigatran” (Pradaxa®), commonly used to clear blood clots. Can

DRUG NEWS: Genentech will showcase the breadth and promise of their Neuroscience Portfolio at the 2019 American Academy of Neurology Annual Meeting. It includes new

MEDICATION VIDEO + ARTICLE: Scientists found drug developed for diabetes “significantly reversed memory loss” in Alzheimer’s mice, through a triple method of action. See why

CLINICAL TRIALS: Find out why researchers think spraying nasal insulin through the nose can improve cognition, memory and daily function in people with Alzheimer’s. Learn

CLINICAL TRIAL NEWS – VIDEO + ARTICLE: Skeptical Alzheimer’s experts expressed surprising optimism regarding Biogen’s BAN-2401 drug. Dr. Ronald Peterson is one of the world’s

TIME MAGAZINE VIDEO: See Peter Wooding and his wife battle Alzheimer’s, 18 months into the Aducanamab Clinical Trial. On FDA’s Fast-Track program, the new vaccine’s

Dr. Richard Taylor has Alzheimer’s and the right attitude!

Swedish researchers find that cholinesterase inhibitors provide cognitive benefits and reduce mortality for up to five years after an Alzheimer’s diagnosis. One medication significantly reduced the risk of developing severe dementia.

Researchers find optimistic people contribute to the health of their partners, staving off risk factors leading to Alzheimer’s disease, other dementias and cognitive decline as they grow old together.

In a study on health & cynicism, people were asked how much they agree with statements such as, “I think most people would lie to get ahead,” and “It is safer to trust nobody”. The clear connection between their answers and their risk of dementia may startle you.

Lewis Hornby had a problem: his grandmother with dementia wasn’t drinking enough, causing her to get severely dehydrated.

Dr. Richard Taylor has Alzheimer’s and the right attitude!

Swedish researchers find that cholinesterase inhibitors provide cognitive benefits and reduce mortality for up to five years after an Alzheimer’s diagnosis. One medication significantly reduced the risk of developing severe dementia.
No spam, only news and updates.


